Advertisement

Topics

EU OKs Sanofi, Regeneron's biologic for rheumatoid arthritis

05:04 EDT 29 Jun 2017 | SmartBrief

European regulators approved Sanofi and Regeneron's Kevzara, or sarilumab, as a treatment for adults with moderately to sever -More

Original Article: EU OKs Sanofi, Regeneron's biologic for rheumatoid arthritis

NEXT ARTICLE

More From BioPortfolio on "EU OKs Sanofi, Regeneron's biologic for rheumatoid arthritis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...